Study procedure
Graves’ orbitopathy, CM, EUGOGO
THYROID
We collected sociodemographic data from the study participants such as age, sex, and smoking history (mild is less than 10 cigarettes per day and heavy is equal or more than 20 cigarettes per day). In addition, we evaluated patients for GO based on the European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines (To ensure standardization of the ATDs, we chose CM as the preferred treatment based on the American Thyroid Association (ATA) guidelines, which recommend it as the preferred ATDs for adults due to its reduced risk of major side effects compared with propyl thiouracil (PTU) (